Suppr超能文献

围手术期静脉输注葡萄糖能否减少术后恶心呕吐?一项系统评价与荟萃分析。

Does perioperative intravenous dextrose reduce postoperative nausea and vomiting? A systematic review and meta-analysis.

作者信息

Kim Seung Hyun, Kim Do-Hyeong, Kim Eungjin, Kim Hyun Jung, Choi Yong Seon

机构信息

Department of Anesthesiology and Pain Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea,

出版信息

Ther Clin Risk Manag. 2018 Oct 15;14:2003-2011. doi: 10.2147/TCRM.S178952. eCollection 2018.

Abstract

PURPOSE

Perioperative dextrose-containing fluid administration has been used as a non-pharmacologic preventive measure against postoperative nausea and vomiting (PONV), a common and distressing complication of anesthesia. However, its efficacy remains unclear as previous studies reported inconsistent results. Our objective was to compare dextrose-containing fluid with non-dextrose-containing fluid in terms of PONV for 24 hours after surgery under general anesthesia. The effects of dextrose according to different types of surgery and the fluid volume were also examined.

METHODS

We performed a systematic review and meta-analysis of randomized controlled trials (RCTs) comparing dextrose-containing fluid with non-dextrose-containing fluids after general anesthesia in terms of PONV incidence and the need for rescue anti-emetic therapies for 24 hours after surgery. A literature search was performed, using Medline, EMBASE, Cochrane Central Register of Controlled Trials, Web of Science, and Scopus, up to February 2018.

RESULTS

We included seven RCTs. Compared with the control group, perioperative dextrose administration did not reduce the risk for PONV, with a relative risk (RR) of 0.72 (95% CI: 0.50-1.03). However, perioperative dextrose reduced the requirement for anti-emetics, compared with the control group, with a RR of 0.60 (95% CI: 0.44-0.83). The quality of evidence in this meta-analysis was poor due to high risks of selection and performance biases and substantial statistical heterogeneity. After subgroup analysis, the risk for PONV was reduced in patients who had undergone laparoscopic cholecystectomy, but not other surgeries, and the effects of dextrose on the risk for PONV did not differ according to the fluid volume administered.

CONCLUSION

Perioperative intravenous (i.v.) dextrose did not reduce the risk for PONV. However, it did reduce the need for anti-emetics after general anesthesia. Furthermore, the effects of dextrose varied according to the surgery type. Further studies are needed to determine the benefits of perioperative i.v. dextrose administration as a preventive measure against PONV.

摘要

目的

围手术期给予含葡萄糖液体一直被用作预防术后恶心呕吐(PONV)的非药物性措施,术后恶心呕吐是麻醉常见且令人困扰的并发症。然而,由于先前研究报告的结果不一致,其疗效仍不明确。我们的目的是比较含葡萄糖液体和不含葡萄糖液体在全身麻醉术后24小时内预防PONV的效果。还研究了不同手术类型和液体量情况下葡萄糖的作用。

方法

我们对随机对照试验(RCT)进行了系统评价和荟萃分析,比较全身麻醉后含葡萄糖液体和不含葡萄糖液体在术后24小时内PONV发生率以及使用补救性止吐治疗的必要性。利用Medline、EMBASE、Cochrane对照试验中央注册库、科学网和Scopus进行文献检索,截至2018年2月。

结果

我们纳入了7项RCT。与对照组相比,围手术期给予葡萄糖并未降低PONV风险,相对风险(RR)为0.72(95%CI:0.50 - 1.03)。然而,与对照组相比,围手术期给予葡萄糖降低了止吐药的使用需求,RR为0.60(95%CI:0.44 - 0.83)。由于存在选择和实施偏倚的高风险以及显著的统计异质性,本荟萃分析中的证据质量较差。亚组分析后发现,接受腹腔镜胆囊切除术的患者PONV风险降低,但其他手术患者未降低,且葡萄糖对PONV风险的影响不因给予的液体量而有所不同。

结论

围手术期静脉输注葡萄糖并未降低PONV风险。然而,它确实减少了全身麻醉后止吐药的使用需求。此外,葡萄糖的作用因手术类型而异。需要进一步研究以确定围手术期静脉输注葡萄糖作为预防PONV措施的益处。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验